feed,title,long_url,short_url
Benzinga,"Adaptimmune's Cancer Candidate Shows 44% Response Rate In Pretreated Ovarian, Urothelial, Head & Neck Cancers",https://benzinga.com/general/biotech/22/09/28810796/adaptimmunes-cancer-candidate-shows-44-response-rate-in-pretreated-ovarian-urothelial-head-neck-c,https://bit.ly/3RPocnc
Benzinga,Robinhood Launches Index Of Highest-Conviction Stocks: Here Are The Top 10 Holdings,https://benzinga.com/news/22/09/28811056/robinhood-launches-index-of-its-highest-conviction-stocks-here-are-the-top-10-holdings,https://bit.ly/3RsBAxE
Benzinga,Nikola Insider Trades Send a Signal,https://benzinga.com/news/22/09/28811167/nikola-insider-trades-send-a-signal,https://bit.ly/3QsBvst
Benzinga,Credo Technology Group Chief Operating Officer Trades Company's Stock,https://benzinga.com/news/22/09/28811164/credo-technology-group-chief-operating-officer-trades-companys-stock,https://bit.ly/3RPSAh3
Benzinga,Credo Technology Group Chief Technology Officer Trades Company's Stock,https://benzinga.com/news/22/09/28811156/credo-technology-group-chief-technology-officer-trades-companys-stock,https://bit.ly/3RVxtKx
